An HPLC purity percentage on a peptide certificate of analysis measures UV peak area, not peptide mass, and the LC-MS trace proves identity rather than quantity. This guide explains the chemistry behind both measurements, why co-eluting deletion sequences and isobaric epimers escape routine…
An HPLC purity percentage and an LC-MS trace on a peptide certificate of analysis answer different questions, and treating them as interchangeable is the most common error in reading one. The purity percentage is an area ratio calculated from ultraviolet absorbance. It describes what fraction of the UV-detectable material eluted as the main peak. The mass spectrum establishes that a species with the expected mass is present. Neither measurement tells you how much of the powder in the vial is actually the peptide you ordered, and both can look clean while real contamination is present. Three separate pieces of information are needed to trust a vial: identity, relative purity, and mass-based content. A certificate that supplies only the first two leaves the third unanswered. This article explains what each number can and cannot demonstrate, why the blind spots exist, and what a buyer can check before relying on a certificate.
Reversed-phase HPLC separates peptides by hydrophobicity. The sample is applied to a C18 silica stationary phase and eluted with a gradient of water and acetonitrile modified with trifluoroacetic acid. Peptides that present more nonpolar surface area are retained longer, so species that differ in sequence, length, or modification often emerge at different times. The physical basis of the separation is well understood. Molecular dynamics simulations show retention arising from contacts between nonpolar side chains such as leucine, isoleucine, and valine and the C18 chains, with desorption proceeding stepwise from the charged termini PMID 36745777 . This is why a single residue change can shift a retention time enough to separate a deletion impurity from the target peptide, and also why some changes do not.
The detector defines what the purity number means. Peptide bonds absorb ultraviolet light at 214 nm, and the aromatic residues tryptophan and tyrosine absorb at 280 nm. Routine certificates usually report purity from 214 nm, where essentially every peptide bond contributes. The percentage is computed by integrating the main peak and dividing by the total integrated area of all detected peaks. That ratio answers one question: of the material that absorbed at the monitored wavelength, what fraction eluted as the main peak?
It does not answer the question most buyers actually have, which is what fraction of the vial contents by weight is the target peptide. UV absorbance is a property of the peptide backbone, not a measurement of mass. Whatever does not absorb at the monitored wavelength is invisible to the integration, and lyophilized peptides contain a great deal of material that is invisible. Trifluoroacetate counter-ions, residual acetate, inorganic salts, and water all add mass to the vial while contributing no peak area. A peptide reported at 98% by HPLC area can therefore be substantially below 98% of the vial contents by weight.
The gap is not a rounding error. For a lyophilized trifluoroacetate salt peptide, the difference between the reported HPLC area percentage and the net peptide content can reach 20 percentage points or more. Some certificates address this with a separate net peptide content figure, usually determined by amino acid analysis or nitrogen determination. Those methods measure peptide mass directly and are the correct basis for any application where the amount of peptide added to a reaction or formulation matters. The figure is frequently absent from certificates, and that absence is a legitimate reason to request it before using the reported purity for quantitative work.
The LC-MS trace on a certificate exists to confirm identity. In electrospray ionization, the peptide acquires multiple charges, producing a ladder of multiply charged ions. Deconvolution collapses that ladder into a single observed mass, which is compared with the theoretical mass of the intended sequence. A match means the sample contains a species with the expected molecular formula, which is a different and much weaker statement than that the sample is pure.
That comparison is genuinely informative, because many common synthesis failures change mass in a predictable way. Mass-differing impurities that co-elute under UV can be exposed by the mass spectrum:
| Mass shift | Most likely assignment |
|---|---|
| -57 Da | Deletion sequence missing one glycine residue |
| +16 Da | Oxidized methionine |
| +56 Da | Incompletely removed tert-butyl protecting group |
| +96 Da | Trifluoroacetylated peptide |
A certificate showing a clean deconvoluted mass at the expected value, with no peaks at these offset masses, provides real evidence that the dominant UV peak is the intended sequence rather than a deletion or adduct. This is the strongest use of the LC-MS trace: identity confirmation with diagnostic mass shifts.
What the trace does not provide is quantity. Ion intensity in the source does not track molar amount. Ionization efficiency varies by orders of magnitude between species, depending on charge state, hydrophobicity, and competition for available charge. A minor impurity that ionizes well can dominate the apparent total ion current, while a poorly ionizing impurity can be nearly invisible at a substantial concentration. Quantitative mass spectrometry requires isotopically labelled internal standards and a calibration curve, and routine certificates include neither. A mass spectrum that confirms the target mass says nothing about what fraction of the vial contents is the target peptide.
There is also a class of impurity that mass spectrometry cannot see at all. Replacing an L-amino acid with its D-enantiomer does not change the molecular mass, so epimers are isobaric with the intended sequence and produce no distinguishing mass signal. The analytical literature treats this as an open problem: a review of enantiomeric purity in synthetic therapeutic peptides concludes that sensitive quantitation of D-isomeric impurities is analytically challenging and that the published evidence remains sparse PMID 38448043 . The risk is concentrated in specific residues. Cysteine and histidine are the residues at greatest risk of racemization during synthesis, and the risk increases with longer coupling times, greater exposure to base, and higher temperature.
The cleanest looking chromatogram can be the most misleading. Co-eluting impurities can hide beneath the target peak and integrate as a single species. Deletion sequences differing by one residue, and epimers formed by racemization, can share a retention time with the target under a shallow gradient, producing one symmetric peak that contains several species. The area-percent calculation then reports a single number for a mixture. A chromatogram with one sharp, symmetric peak is not proof of a single species.
The same sample can yield different purity numbers depending on how the analysis was run and processed. Integration is an operator decision: where the baseline is drawn, where peak start and end points are set, and how valley points are assigned all change the ratio. Gradient shape and detector wavelength change what is resolved and what is detected in the first place. Separation conditions determine which impurities are resolved at all, and the tutorial literature is explicit that understanding chromatographic fundamentals is a prerequisite for interpreting what advanced instruments report about a peptide sample PMID 36355445 .
Presentation can add another layer of concealment. A compressed time axis or a truncated baseline hides late-eluting material: hydrophobic impurities that emerge after the main peak simply never appear in the displayed window, and the integration never sees them. A mass spectrum confirming the target mass does not rescue this, because identity confirmation and quantity determination remain separate questions.
The way to tell whether the reported purity reflects the vial is to ask for the evidence behind each number and to request the one measurement certificates most often omit. The three certificate metrics answer different questions, and a complete picture requires all three:
| Certificate metric | How it is measured | Question it answers | Valid for weighing doses? |
|---|---|---|---|
| HPLC area purity | UV integration at 214 nm or 280 nm | What fraction of UV-detectable material is the main peak? | No. Ignores counter-ions, salts, and water |
| LC-MS mass match | Electrospray ionization and deconvolution | Is the expected sequence present? | No. Ion intensity is not quantitative |
| Net peptide content | Amino acid analysis or nitrogen determination | What fraction of vial mass is peptide? | Yes, when measured |
These checks are cheap relative to the cost of an experiment built on a wrong peptide mass. For most research applications, the combination of a verified chromatogram, a confirmed mass, and a measured net peptide content removes the ambiguity that any single certificate figure leaves open.
The analytical chemistry behind these limitations is well established, and the published record supports the mechanistic claims. The molecular dynamics work on peptide retention PMID 36745777 explains why small sequence changes alter hydrophobicity in predictable ways, which is exactly why deletion impurities can sometimes be resolved by chromatography and sometimes co-elute with the target. The chromatographic tutorial literature makes the same point at the level of practice, correlating current practice trends with established knowledge of separation fundamentals PMID 36355445 . Reversed-phase chromatography is also the standard workhorse of peptide purification at laboratory scale, as demonstrated by high-performance flash chromatography purifications of synthetic peptides and modified insulins PMID 33443297 , so the behavior of a C18 column under water-acetonitrile gradients is among the most studied separation systems in chemistry.
What the published record does not contain is a systematic body of data on how often certificate-reported HPLC purity overstates the independently measured net peptide content of commercial lots. The mechanism is beyond dispute: UV area percentage and peptide mass are different quantities, and non-UV-absorbing counter-ions and water are present in every lyophilized peptide salt. The prevalence of overstated purity on real certificates has not been quantified in the peer-reviewed literature in any general way, and the epimer problem is explicitly described as under-studied PMID 38448043 . A buyer should treat the mechanism as settled and the prevalence data as absent.
That distinction matters for practical decisions. When a certificate reports 98% HPLC purity and no net peptide content, the honest reading is not that 98% of the vial is peptide. The honest reading is that 98% of the UV-detectable material eluted as the main peak, and that the peptide content by weight was not measured. Those two statements can describe the same vial, and they can describe very different vials. The certificate itself does not tell you which one you are holding.
PMID 36355445 - Reversed-Phase Liquid Chromatography of Peptides for Bottom-Up Proteomics: A Tutorial. Journal of Proteome Research, 2022. https://pubmed.ncbi.nlm.nih.gov/36355445/
PMID 38448043 - Enantiomeric purity of synthetic therapeutic peptides: A review. Chirality, 2024. https://pubmed.ncbi.nlm.nih.gov/38448043/
PMID 36745777 - Atomistic Details of Peptide Reversed-Phase Liquid Chromatography from Molecular Dynamics Simulations. Analytical Chemistry, 2023. https://pubmed.ncbi.nlm.nih.gov/36745777/
PMID 33443297 - High-Performance Reversed-Phase Flash Chromatography Purification of Peptides and Chemically Modified Insulins. Chembiochem, 2021. https://pubmed.ncbi.nlm.nih.gov/33443297/
Related reading: Manual Fmoc Solid-Phase Peptide Synthesis: A Beginner's Protocol, API Contract Manufacturing: Process, Benefits, and Partner Selection, Synthesizing Peptides Over 100 Amino Acids: Methods and Examples, Tag-Assisted Peptide Synthesis: How TAPS Works and Its Benefits.